1.Interpretation of the key points of "Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries"
Peiyu WANG ; Qi HUANG ; Shaodong WANG ; Xiankai CHEN ; Ruixiang ZHANG ; Jia ZHAO ; Mantang QIU ; Yin LI ; Xiangnan LI
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2024;31(07):933-954
"Global cancer statistics 2022" based on the latest GLOBCAN data from the International Agency for Research on Cancer (IARC) was recently released, providing a systematic analysis of the incidence and mortality of 36 types of cancer across 185 countries worldwide. The international burden of cancer is expected to continue to increase over the next 30 years, posing a severe public health and social challenge for many countries, including China. This article offers a key point interpretation of the "Global cancer statistics 2022", focusing on the evolution of cancer epidemiology and future development trends. The aim is to broaden the international perspective on cancer prevention and treatment, with the hope of providing reference and guidance for cancer prevention and treatment efforts in our country.